Rate My Professor Adrian McElholm

Adrian McElholm, MD, FRCP(UK), FRACP, is a consultant gastroenterologist and hepatologist with a strong foundation in academic medicine and advanced clinical training. He graduated with distinction from Queen’s University in Belfast in 1997, obtaining his Bachelor of Medical Science (BMedSc) and Bachelor of Medicine, Bachelor of Surgery and Bachelor of Obstetrics (MBBChBAO). In 2002, he achieved Membership of the Royal College of Physicians (MRCP London). His Doctor of Medicine (MD) was awarded in 2012 by Queen’s University Belfast for research investigating reflux oesophagitis, Barrett’s oesophagus, and oesophageal cancer. He was elected Fellow of the Royal College of Physicians (UK) in 2013 and gained Fellowship of the Royal Australian College of Physicians (FRACP) in 2014.

Dr McElholm undertook postgraduate training in clinical pharmacology and therapeutics in Northern Ireland, followed by specialist training in gastroenterology and general medicine in the Northern Ireland Deanery. He completed advanced fellowships in interventional endoscopy at Royal Perth Hospital, Western Australia, and Royal Bournemouth Hospital, England. Appointed consultant gastroenterologist and hepatologist in Liverpool, UK, in 2012, he relocated to Perth in 2013. He currently holds positions as consultant gastroenterologist and general physician at Rockingham General Hospital and Fiona Stanley Hospital, with private practices at St John of God Murdoch Hospital, Murdoch Square, and Southcare Group. His interests include reflux disease, Barrett’s oesophagus, interventional endoscopy, general adult gastroenterology, hepatology, and endoscopy. Key publications include 'Prevalence of gastrointestinal malignancy in non-anemic iron deficiency and significance for endoscopic practice' (Journal of Gastroenterology and Hepatology, 2023) and earlier works such as 'A population-based study of polymorphisms of the Insulin-like growth factor axis and risk of esophageal adenocarcinoma' and studies on IGF axis polymorphisms in the esophageal inflammation, metaplasia, adenocarcinoma sequence (British Society of Gastroenterology, 2009).